Tag: Synchron
Synchron launches patient registry for Stentrode brain-computer interface
Synchron has announced the launch of a community-centred brain-computer interface (BCI) registry to bring patients, carers and clinicians together to learn how BCI technology...
Synchron acquires equity stake in Acquandas
Endovascular brain-computer interface (BCI) technology firm Synchron has announced the acquisition of an equity stake in Acquandas—a leading technology provider specialising in state-of-the-art, high-precision components...
Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to...
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
Synchron announces first human brain-computer interface implant in the USA
Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...
Synchron enrols first patient in US COMMAND study of endovascular brain-computer...
Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...
Synchron announces long-term safety results with Stentrode device for severe paralysis
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...
Brain-computer interface technology opens up “whole new world” of therapies
“We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
Synchron announces US$10 million NIH grant for US COMMAND trial
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
Synchron given green light to begin US study of endovascular brain-computer...
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...
Stentrode brain-computer interface receives breakthrough device designation from FDA
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Stentrode brain-computer interface for its fully-implantable medical device that can...
LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient
According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
Synchron secures funding to advance commercialisation of Stentrode
Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...
BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous...
Synchron recently announced the first successful implant of its minimally-invasive neural interface technology (Stentrode) as part of a trial evaluating the safety and efficacy of...
